Changes of host immunity in relation to efficacy in liver cirrhosis patients with advanced hepatocellular carcinoma treated by intra-arterial chemotherapy

Cancer Chemotherapy and Pharmacology

Volumn 64, Issue 2, 2009, Pages 271-277

  Momiyama, Kouichi ^a   Nagai, Hidenari ^a   Sumino, Yasukiyo ^a  

^a TOHO UNIVERSITY OMORI MEDICAL CENTER   (Japan)

Author keywords

Advanced HCC; Host immunity; Intra arterial chemotherapy; Liver cirrhosis; Th1 Th2 balance

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CD4 ANTIGEN; CISPLATIN; FLUOROURACIL; FOLINIC ACID; GAMMA INTERFERON; INTERLEUKIN 4;

ADULT; ADVANCED CANCER; AGED; ALCOHOL ABUSE; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CLINICAL ARTICLE; COMORBIDITY; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; FEMALE; FLOW CYTOMETRY; HEPATITIS B; HEPATITIS C; HUMAN; IMMUNITY; JAPANESE; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LOW DRUG DOSE; MALE; PRIORITY JOURNAL; TH1 CELL; TH2 CELL; TREATMENT RESPONSE; TUMOR VOLUME;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; CISPLATIN; FEMALE; FLOW CYTOMETRY; FLUOROURACIL; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HUMANS; IMMUNITY; INFUSIONS, INTRA-ARTERIAL; LEUCOVORIN; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; RETROSPECTIVE STUDIES; SURVIVAL RATE; TH1 CELLS; TH2 CELLS; TREATMENT OUTCOME;

EID: 67349101689     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-008-0866-8     Document Type: Article

References (47)

1. K Okuda I Fujimoto A Hanai Y Urano 1987 Changing incidence of hepatocellular carcinoma in Japan Cancer Res 47 4967 4972 (Pubitemid 17143048)
2. SH Landis T Murray S Bolden PA Wingo 1998 Cancer statistics CA Cancer J Clin 48 6 29
3. HB El-Serag AC Mason 1999 Rising incidence of hepatocellular carcinoma in the United States N Engl J Med 340 745 750 (Pubitemid 29114292)
4. SD Taylor-Robinson GR Foster S Arora S Hargreaves HC Thomas 1997 Increase in primary liver cancer in the UK 1979-1994 Lancet 350 1142 1143 (Pubitemid 27454010)
5. S Deuffic T Poynard L Buffat AJ Valleron 1998 Trends in primary liver cancer Lancet 351 214 215
6. K Okuda T Ohtsuki H Obata M Tomimatsu N Okazaki H Hasegawa Y Nakajima K Ohnishi 1985 Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients Cancer 56 918 928 (Pubitemid 15228292)
7. N Nagasue H Yukaya T Hamada S Hirose R Kanashima K Inokuchi 1984 The natural history of hepatocellular carcinoma. A study of 100 untreated cases Cancer 54 1461 1465 (Pubitemid 14003554)
8. W Ensminger J Niederhuber S Dakhil J Thrall R Wheeler 1981 Totally implanted drug delivery system for hepatic arterial chemotherapy Cancer Treat Rep 65 393
9. H Toyoda S Nakano T Kumada I Takeda K Sugiyama T Osada S Kiriyama T Suga M Takahashi 1995 The efficacy of continuous local arterial infusion of 5-fluorouracil and cisplatin through an implanted reservoir for severe advanced hepatocellular carcinoma Oncology 52 295 299
10. K Murata K Shiraki T Kawakita N Yamamoto H Okano M Nakamura T Sakai M Deguchi S Ohmori T Nakano 2003 Low-dose chemotherapy of cisplatin and 5-fluorouracil or doxorubicin via implanted fusion port for unresectable hepatocellular carcinoma Anticancer Res 3 1719 1722 (Pubitemid 36750837)
11. K Okuda M Tanaka J Shibata E Ando T Ogata H Kinoshita N Eriguchi S Aoyagi K Tanikawa 1999 Hepatic arterial infusion chemotherapy with continuous low dose administration of cisplatin and 5-fluorouracil for multiple recurrence of hepatocellular carcinoma after surgical treatment Oncol Rep 6 587 591
12. H Nagai T Matsui M Kanayama K Momiyama A Ikoma N Okano T Ikehara K Matsumaru M Watanabe K Iida K Ishii Y Sumino K Miki 2007 Assessment of combined intra-arterial low-dose 5-fluorouracil, cisplatin, and leucovolin chemotherapy for patients with advanced hepatocellular carcinoma using the Japan integrated staging score J Med Soc Toho 54 21 28
13. H Nagai M Kanayama K Higami K Momiyama A Ikoma N Okano K Matsumaru M Watanabe K Ishii Y Sumino K Miki 2007 Twenty-four hour intra-arterial infusion of 5-fluorouracil, cisplatin, and leucovorin is more effective than 6-hour infusion for advanced hepatocellular carcinoma World J Gastroenterol 13 2 280 284 (Pubitemid 46231333)
14. M Kobayashi H Kobayashi RB Pollard F Suzuki 1998 A pathogenic role of Th2 cells and their cytokine products on the pulmonary metastasis of murine B16 melanoma J Immunol 160 5869 5873 (Pubitemid 28298045)
15. L Zitvogel JI Mayordomo T Tjandrawan AB DeLeo MR Clarke MT Lotze WJ Storkus 1996 Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines J Exp Med 183 87 97 (Pubitemid 26028748)
16. H-M Hu WJ Urba BA Fox 1998 Gene-modified tumor vaccine with therapeutic potential shifts tumor-specific T cell response from type 2 to a type 1 cytokine profile J Immunol 161 3033
17. K Fukuzawa K Takahashi K Furuta T Tagaya T Ishikawa K Wada Y Omoto T Koji S Kakumu 2001 Expression of Fas/Fas ligand and its involvement in infiltrating lymphocytes in hepatocellular carcinoma J Gastroenterol 36 681 688 (Pubitemid 33040941)
18. E Yakirevich O Lefel Y Sova A Stein O Cohen OB Izhak MB Resnick 2002 Activated status of tumour-infiltrating lymphocytes and apoptosis in testicular seminoma J Pathol 196 67 75
19. M Ikeguchi K Oi Y Hirooka N Kaibara 2004 CD8+ lymphocyte infiltration and apoptosis in hepatocellular carcinoma Eur J Surg Oncol 30 53 57 (Pubitemid 38180992)
20. S Sakaguchi 2004 Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses Annu Rev Immunol 22 531 562 (Pubitemid 38680433)
21. E Unitt SM Rushbrook A Marshall S Davies P Gibbs LS Morris N Coleman GJ Alexander 2005 Compromised lymphocytes infiltrate hepatocellular carcinoma: the role of T-regulatory cells Hepatology 41 722 730 (Pubitemid 40462933)
22. LA Ormandy T Hillemann H Wedemeyer MP Manns TF Greten F Korangy 2005 Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma Cancer Res 65 2457 2464 (Pubitemid 40490158)
23. XH Yang S Yamagiwa T Ichida Y Matsuda S Sugahara H Watanabe Y Sato T Abo DA Horwitz Y Aoyagi 2006 Increase of CD4+ CD25+ regulatory T cells in the liver of patients with hepatocellular carcinoma J Hepatol 45 254 262
24. Nagai H, Miyaki D, Matsui T, Kanayama M, Higami K, Momiyama K, Ikehara T, Watanabe M, Sumino Y, Miki K (2008) Th1/Th2 balance: an important indicator of efficacy for intra-arterial chemotherapy. Cancer Chemother Pharmacol Feb 8. [Epub ahead of print]
25. [25] Iwamiya T, Sawada S, and Ohta Y. Repeated arterial infusion chemotherapy for inoperable hepatocellular carcinoma using an implantable drug delivery system. Cancer Chemother Pharmacol 1994;33(Suppl):S134-S138 (Pubitemid 24147983)
26. M Shinohara K Ishii N Takamura 2003 Long-term changes of peripheral blood CD4-positive T cell subsets (Th1, Th2) in chronic hepatitis C patients with a sustained response no response to IFN Hepatol Res 27 260 265 (Pubitemid 38009010)
27. T Jung U Schauer C Heusser C Neumann C Rieger 1993 Detection of intracellular cytokines by flow cytometry J Immunol Methods 159 197 207
28. M Kudo H Chung Y Osaki 2003 Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for new staging system, the Japan Integrated Staging score (JIS score) J Gastroenterol 38 207 215 (Pubitemid 36527122)
29. D Gabrilovich 2004 Mechanisms and functional significance of tumor-induced dendritic-cell defects Nat Rev Immunol 4 941 952 (Pubitemid 39620069)
30. TK Hoffmann J Muller-Berghaus RL Ferris JT Johnson WJ Storkus TL Whiteside 2002 Alterations in the frequency of dendritic cell subsets in the peripheral circulation of patients with squamous cell carcinoma of the head and neck Clin Cancer Res 8 1787 1793 (Pubitemid 34633736)
31. S Della Bella M Gennaro M Vaccari C Ferraris S Nicola A Riva 2003 Altered maturation of peripheral blood dendritic cells in patients with breast cancer Br J Cancer 89 1463 1472 (Pubitemid 37386601)
32. DI Gabrilovich J Corak IF Ciernik D Kavanaugh DP Carbone 1997 Decreased antigen presentation by dendritic cells in patients with breast cancer Clin Cancer Res 3 483 490 (Pubitemid 27158075)
33. T Ishida T Oyama DP Carbone DI Gabrilovich 1998 Defective function of langerhans cells in tumor-bearing animals is the results of defective maturation from hemopoietic progenitors J Immunol 161 4842 4851 (Pubitemid 28492062)
34. LA Ormandy A Farber T Cantz S Petrykowska H Wedemeyer M Horning 2006 Direct ex vivo analysis of dendritic cells in patients with hepatocellular carcinoma World J Gastroenterol 12 3275 3282 (Pubitemid 43881355)
35. DI Gabrilovich T Ishida S Nadaf JE Ohm DP Carbone 1999 Antibodies to vascular endothelial growth factor enhance the efficacy of cancer immunotherapy by improving endogenous dendritic cell function Clin Cancer Res 5 2963 2970 (Pubitemid 29493976)
36. D Gabrilovich T Ishida T Oyama S Ran V Kravtsov S Nadaf DP Carbone 1998 Vascular endothelial growth factor inhibits the development of dendritic cell and dramatically affects the differentiation of multiple hematopoietic lineages in vivo Blood 92 4150 4166 (Pubitemid 28544331)
37. JE Ohm MR Shurin C Esche MT Lotze DP Carbone DI Gabrilovich 1999 Effect of vascular endothelial growth factor and FLT3 ligand on dendritic cell generation in vivo J Immunol 163 3260 3268 (Pubitemid 29431827)
38. C Menetrier-Caux G Montmain MC Dieu C Bain MC Favrot C Caux JY Blay 1998 Inhibition of the differentiation of dendritic cells from CD34(+) progenitors by tumor cells: role of interleukin-6 and macrophage colony-stimulating factor Blood 92 4778 4791 (Pubitemid 29005881)
39. M Ratta F Fagnoni A Curti R Vescovini P Sansoni M Fogli B Oliviero E Ferri GR Della Cuna S Tura M Baccarani RM Lemoli 2002 Dendritic cells are functionally defective in multiple myeloma: the role of interleukin-6 Blood 100 230 237 (Pubitemid 35177452)
40. SJ Park T Nakagawa H Kitamura T Atsumi H Kamon S Sawa D Kamimura N Ueda Y Iwakura K Ishihara M Murakami T Hirano 2004 IL-6 regulates in vivo dendritic cell differentiation through STAT3 activation J Immunol 173 3844 3854 (Pubitemid 39280747)
41. AS Yang EC Lattime 2003 Tumor-induced interleukin 10 suppresses the ability of splenic dendritic cells to stimulate CD4 and CD8 T-cell responses Cancer Res 63 2150 2157 (Pubitemid 36538620)
42. S Beissert J Hosoi S Grabbe A Asahina RD Granstein 1995 IL-10 inhibits tumor antigen presentation by epidermal antigen-presenting cells J Immunol 154 1280 1286
43. K Steinbrink E Graulich S Kubsch J Knop AH Enk 2002 CD4(+) and CD8(+) anergic T cells induced by interleukin-10-treated human dendritic cells display antigen-specific suppressor activity Blood 99 2468 2476 (Pubitemid 34525434)
44. DI Gabrilovich HL Chen KR Girgis HT Cunningham GM Meny S Nadaf D Kavanaugh DP Carbone 1996 Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells Nat Med 2 1096 1103 (Pubitemid 26338628)
45. N Ferrara HP Gerber J LeCounter 2003 The biology of VEGF and its receptors Nat Med 9 669 676 (Pubitemid 36749215)
46. F Korangy LA Ormandy JS Bleck J Klempnauer L Wilkens MP Manns TF Greten 2004 Spontaneous tumor-specific humoral and cellular immune responses to NY-ESO-1 in hepatocellular carcinoma Clin Cancer Res 10 4332 4341 (Pubitemid 38878871)
47. T Matsui H Nagai Y Sumino K Miki 2008 Relationship of peripheral blood CD4-positive T cells to carcinogenesis in patients with HCV-related chronic hepatitis and liver cirrhosis Cancer Chemother Pharmacol 62 401 406